Kadmon Announces Supplemental Interim Phase 2 Data of KD025 in Chronic Graft-Versus-Host Disease
Kadmon Holdings, Inc. (KDMN)
Last kadmon holdings, inc. earnings: 3/5 04:14 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.kadmon.com
Company Research
Source: Business Wire
NEW YORK--(BUSINESS WIRE)-- Kadmon Holdings, Inc. (NYSE: KDMN) (“Kadmon” or the “Company”) today announced supplemental clinical data from the first cohort (KD025 200 mg QD) of an ongoing Phase 2 clinical trial (KD025-208) of the Company’s lead Rho-associated coiled-coil kinase 2 (“ROCK2”) inhibitor, KD025, for chronic graft-versus-host disease (“cGVHD”). The Company first announced clinical data from the study on July 11, 2017. The data points, which were pending at the time of the prior data release, are as follows: An additional responder sustained a response through 24 weeks of KD025 treatment. Of responders remaining on KD025 through 24 weeks, 8 of 9 (89%) sustained responses, up from 7 of 8 patients (88%) previously reported. An additional patient achieved stable disease at week 24. This finding brings the number of patients with stable disease at week 24 to th
Show less
Read more
Impact Snapshot
Event Time:
KDMN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KDMN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KDMN alerts
High impacting Kadmon Holdings, Inc. news events
Weekly update
A roundup of the hottest topics